DK353788A - Polypeptidderivater - Google Patents

Polypeptidderivater

Info

Publication number
DK353788A
DK353788A DK353788A DK353788A DK353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A
Authority
DK
Denmark
Prior art keywords
polypeptide
Prior art date
Application number
DK353788A
Other languages
Danish (da)
English (en)
Other versions
DK353788D0 (da
Inventor
Albert Rainer
Wilfried Bauer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK353788D0 publication Critical patent/DK353788D0/da
Publication of DK353788A publication Critical patent/DK353788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK353788A 1987-06-29 1988-06-27 Polypeptidderivater DK353788A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (2)

Publication Number Publication Date
DK353788D0 DK353788D0 (da) 1988-06-27
DK353788A true DK353788A (da) 1988-12-30

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK353788A DK353788A (da) 1987-06-29 1988-06-27 Polypeptidderivater

Country Status (15)

Country Link
JP (1) JPS6426599A (cs)
KR (1) KR890000520A (cs)
AU (1) AU1840988A (cs)
BE (1) BE1002663A4 (cs)
CH (1) CH679045A5 (cs)
DK (1) DK353788A (cs)
ES (1) ES2010283A6 (cs)
FR (1) FR2617171B1 (cs)
GB (1) GB2206352B (cs)
IL (1) IL86876A0 (cs)
IT (1) IT1221065B (cs)
LU (1) LU87262A1 (cs)
NL (1) NL8801640A (cs)
NZ (1) NZ225188A (cs)
SE (1) SE8802413L (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
KR0173119B1 (ko) * 1989-04-26 1999-02-01 닐 에이. 밴스로우 선형 소마토스타틴 유사체
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
WO2002010215A1 (en) * 2000-07-31 2002-02-07 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
AU2002258465B2 (en) 2001-03-08 2006-01-19 The Administrators Of The Tulane Educational Fund Somatostatin antagonists
WO2002081499A2 (en) * 2001-04-09 2002-10-17 The Administrators Of The Tulane Educational Fund Somatostatin agonists
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
IT8848133A0 (it) 1988-06-28
LU87262A1 (fr) 1989-03-08
SE8802413L (sv) 1988-12-30
NZ225188A (en) 1991-04-26
ES2010283A6 (es) 1989-11-01
FR2617171B1 (fr) 1994-10-14
NL8801640A (nl) 1989-01-16
IL86876A0 (en) 1988-11-30
GB8815257D0 (en) 1988-08-03
IT1221065B (it) 1990-06-21
SE8802413D0 (sv) 1988-06-28
GB2206352A (en) 1989-01-05
AU1840988A (en) 1989-01-05
JPS6426599A (en) 1989-01-27
BE1002663A4 (fr) 1991-04-30
KR890000520A (ko) 1989-03-15
CH679045A5 (cs) 1991-12-13
GB2206352B (en) 1990-10-31
FR2617171A1 (fr) 1988-12-30
DK353788D0 (da) 1988-06-27

Similar Documents

Publication Publication Date Title
DK97790A (da) Renin-inhiberende peptider
ATA30988A (de) Alpinski
LV10019A (lv) Herbicida sastavs
ATA174488A (de) Alpinski
DK275788D0 (da) Protein
ATA174288A (de) Alpinski
DK353788A (da) Polypeptidderivater
ATA224788A (de) Calcitoninsuppositorien
DK354389D0 (da) Polypeptid
DK492588A (da) Merozoit-antigen polypeptider
AT389045B (de) Paraocclusaler loeffel
ATA48687A (de) Guellefass
ATA294988A (de) Haecksler
DK596888D0 (da) Rekombinant lymfotoksin
DK624089D0 (da) Polypeptidforbindelser
AT388649B (de) Sportschuh
ATA162787A (de) Hoergeraet
DK341687D0 (da) Polypeptider
DK101587D0 (da) Peptider
BR1100729A (pt) Polipeptìdeo modificado
IT8719414V0 (it) Cromagic t
BR6700736U (pt) Fecho
BR6701723U (pt) Nivel-atmosfera-profissional
BR6700994U (pt) Isqueiro-cinzeiro
ATA257287A (de) Glykopeptidantibiotika

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment